Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Solute carrier family 9, subfamily A, member 3 (SLC9A3)/sodium-hydrogen exchanger member 3 (NHE3) dysregulation and dilated intercellular spaces in patients with eosinophilic esophagitis.

Zeng C, Vanoni S, Wu D, Caldwell JM, Wheeler JC, Arora K, Noah TK, Waggoner L, Besse JA, Yamani AN, Uddin J, Rochman M, Wen T, Chehade M, Collins MH, Mukkada VA, Putnam PE, Naren AP, Rothenberg ME, Hogan SP.

J Allergy Clin Immunol. 2018 Dec;142(6):1843-1855. doi: 10.1016/j.jaci.2018.03.017. Epub 2018 May 4.

PMID:
29729938
2.

IL-33 is induced in undifferentiated, non-dividing esophageal epithelial cells in eosinophilic esophagitis.

Travers J, Rochman M, Caldwell JM, Besse JA, Miracle CE, Rothenberg ME.

Sci Rep. 2017 Dec 14;7(1):17563. doi: 10.1038/s41598-017-17541-5.

3.

Paired Ig-like Receptor B Inhibits IL-13-Driven Eosinophil Accumulation and Activation in the Esophagus.

Ben Baruch-Morgenstern N, Mingler MK, Stucke E, Besse JA, Wen T, Reichman H, Munitz A, Rothenberg ME.

J Immunol. 2016 Aug 1;197(3):707-14. doi: 10.4049/jimmunol.1501873. Epub 2016 Jun 20.

4.

Obtaining the Patient's Voice from within Three Patient-Centered Medical Homes.

Kennedy BM, Cerise F, Horswell R, Griffin WP, Willis KH, Moody-Thomas S, Besse JA, Katzmarzyk PT.

Clin Transl Sci. 2015 Aug;8(4):367-75. doi: 10.1111/cts.12192. Epub 2014 Jul 25.

5.

Evaluating A Patient-Centered Medical Home From the Patient's Perspective.

Kennedy BM, Moody-Thomas S, Katzmarzyk PT, Horswell R, Griffin WP, Coleman MT, Herwehe J, Besse JA, Willis KH.

Ochsner J. 2013 Fall;13(3):343-51.

6.

Eosinophil adoptive transfer system to directly evaluate pulmonary eosinophil trafficking in vivo.

Wen T, Besse JA, Mingler MK, Fulkerson PC, Rothenberg ME.

Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6067-72. doi: 10.1073/pnas.1220572110. Epub 2013 Mar 27.

7.

Targeted ablation of miR-21 decreases murine eosinophil progenitor cell growth.

Lu TX, Lim EJ, Itskovich S, Besse JA, Plassard AJ, Mingler MK, Rothenberg JA, Fulkerson PC, Aronow BJ, Rothenberg ME.

PLoS One. 2013;8(3):e59397. doi: 10.1371/journal.pone.0059397. Epub 2013 Mar 22.

8.

MiR-223 deficiency increases eosinophil progenitor proliferation.

Lu TX, Lim EJ, Besse JA, Itskovich S, Plassard AJ, Fulkerson PC, Aronow BJ, Rothenberg ME.

J Immunol. 2013 Feb 15;190(4):1576-82. doi: 10.4049/jimmunol.1202897. Epub 2013 Jan 16.

9.

MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers.

Lu TX, Sherrill JD, Wen T, Plassard AJ, Besse JA, Abonia JP, Franciosi JP, Putnam PE, Eby M, Martin LJ, Aronow BJ, Rothenberg ME.

J Allergy Clin Immunol. 2012 Apr;129(4):1064-75.e9. doi: 10.1016/j.jaci.2012.01.060. Epub 2012 Mar 3.

10.

Diabetes mellitus medication assistance program: relationship of effectiveness to adherence.

Horswell RL, Wascom CK, Cerise FP, Besse JA, Johnson JK.

J Health Care Poor Underserved. 2008 Aug;19(3):677-86. doi: 10.1353/hpu.0.0062.

PMID:
18677064
11.

Acoustic emissions during 3.1 MHz ultrasound bulk ablation in vitro.

Mast TD, Salgaonkar VA, Karunakaran C, Besse JA, Datta S, Holland CK.

Ultrasound Med Biol. 2008 Sep;34(9):1434-48. doi: 10.1016/j.ultrasmedbio.2008.02.007. Epub 2008 Apr 16.

12.

Trends and risk factors for prostate biopsy complications in the pre-PSA and PSA eras, 1980 to 1997.

Roberts RO, Bergstralh EJ, Besse JA, Lieber MM, Jacobsen SJ.

Urology. 2002 Jan;59(1):79-84.

PMID:
11796286
13.

Comparison of screening methods in the detection of bladder cancer.

Ramakumar S, Bhuiyan J, Besse JA, Roberts SG, Wollan PC, Blute ML, O'Kane DJ.

J Urol. 1999 Feb;161(2):388-94.

PMID:
9915409
14.

Neurologic complications of 603 consecutive continuous spinal anesthetics using macrocatheter and microcatheter techniques. Perioperative Outcomes Group.

Horlocker TT, McGregor DG, Matsushige DK, Chantigian RC, Schroeder DR, Besse JA.

Anesth Analg. 1997 May;84(5):1063-70.

PMID:
9141932
15.

A retrospective review of 4767 consecutive spinal anesthetics: central nervous system complications. Perioperative Outcomes Group.

Horlocker TT, McGregor DG, Matsushige DK, Schroeder DR, Besse JA.

Anesth Analg. 1997 Mar;84(3):578-84.

PMID:
9052305

Supplemental Content

Loading ...
Support Center